Lifecare AS (OL:LIFE) — Market Cap & Net Worth
Market Cap & Net Worth: Lifecare AS (LIFE)
Lifecare AS (OL:LIFE) has a market capitalization of $6.29 Million (Nkr59.80 Million) as of August 12, 2026. Listed on the OL stock exchange, this Norway-based company holds position #28130 globally and #249 in its home market, demonstrating a -5.72% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Lifecare AS's stock price Nkr0.31 by its total outstanding shares 191059950 (191.06 Million). See Lifecare AS (LIFE) balance sheet quality index to understand what proportion of total assets are financed by equity.
Lifecare AS Market Cap History: 2018 to 2026
Lifecare AS's market capitalization history from 2018 to 2026. Data shows change from $565.71 Million to $6.29 Million (-41.17% CAGR). Also see LIFE current and non-current assets for a full breakdown of the balance sheet.
Lifecare AS Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Lifecare AS's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check LIFE stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
81.26x
Lifecare AS's market cap is 81.26 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $565.71 Million | $3.49 Million | -$8.79 Million | 162.29x | N/A |
| 2019 | $729.24 Million | $2.07 Million | -$6.56 Million | 352.51x | N/A |
| 2020 | $963.48 Million | $1.67 Million | -$2.74 Million | 576.12x | N/A |
| 2021 | $375.67 Million | $324.41K | -$15.88 Million | 1158.00x | N/A |
| 2022 | $397.77 Million | $16.71 Million | -$17.48 Million | 23.80x | N/A |
| 2023 | $985.58 Million | $13.09 Million | -$35.26 Million | 75.31x | N/A |
| 2024 | $246.29 Million | $3.03 Million | -$71.76 Million | 81.26x | N/A |
Competitor Companies of LIFE by Market Capitalization
Companies near Lifecare AS in the global market cap rankings as of August 12, 2026. Also see LIFE cash generation efficiency for how efficiently the company converts equity into cash flow.
Key companies related to Lifecare AS by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #112 globally with a market cap of $188.88 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #178 globally with a market cap of $132.34 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #237 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #241 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #112 | Abbott Laboratories | NYSE:ABT | $188.88 Billion | $108.62 |
| #178 | Stryker Corporation | NYSE:SYK | $132.34 Billion | $345.81 |
| #237 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #241 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $89.41 |
Lifecare AS Historical Marketcap From 2018 to 2026
Between 2018 and today, Lifecare AS's market cap moved from $565.71 Million to $ 6.29 Million, with a yearly change of -41.17%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Nkr6.29 Million | -90.40% |
| 2025 | Nkr65.54 Million | -73.39% |
| 2024 | Nkr246.29 Million | -75.01% |
| 2023 | Nkr985.58 Million | +147.78% |
| 2022 | Nkr397.77 Million | +5.88% |
| 2021 | Nkr375.67 Million | -61.01% |
| 2020 | Nkr963.48 Million | +32.12% |
| 2019 | Nkr729.24 Million | +28.91% |
| 2018 | Nkr565.71 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 11th, 2026 the market cap of Lifecare AS was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.29 Million USD |
| MoneyControl | $6.29 Million USD |
| MarketWatch | $6.29 Million USD |
| marketcap.company | $6.29 Million USD |
| Reuters | $6.29 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Lifecare AS
Lifecare ASA, together with its subsidiaries, operates as a medical sensor company that develops technology for sensing and monitoring of various body analytes in Norway. The company develops Sencell, a micro sensor for monitoring glucose levels in patients with diabetes and for veterinary applications. It also develops and manufactures a nanostrain biosensor, an ultra-small device that measures … Read more